# REVIEW_REPORT - Cycle 25
_Date: 2026-05-15 · Scope: Phase 20 T83-T87_

## Executive Summary

- Stop-Ship: No
- Phase 20 claim-safe preview and paid CTA packaging is implemented and ready
  for Phase 21 evidence dashboard work.
- `preview build` renders redacted previews with safe counts, rule categories,
  limitation refs, next action, and required disclaimer.
- Paid pilot CTA copy is status-gated and manual-only with no checkout/SaaS
  scope.
- Preview conversion events record privacy-safe local evidence and exclude
  demo/open-source sources from market CTA counts.
- Paid unlock state separates preview-only, paid-requested,
  operator-reviewed, and delivered states; delivery requires claim safety.
- Runtime remains T0 local CLI/file I/O; no hosted accounts, checkout, payment
  processing, background worker, live-control path, or real exchange fetching
  was added.
- Baseline is 240 passing tests, 0 skipped; ruff check and format check pass.

## P0 Issues

None.

## P1 Issues

None.

## P2 Issues

| ID | Description | Files | Status |
|----|-------------|-------|--------|
| None | No P2 findings in Cycle 25. | - | - |

## Carry-Forward Status

| ID | Sev | Description | Status | Change |
|----|-----|-------------|--------|--------|
| T66-P2-001 | P2 | Generic generated report first screen did not explain open-source validation limits. | Closed | Still closed; Phase 20 preview uses safe limitations and claim guard. |
| CODE-1 | P2 | Delivery packet hash absent from manifests in earlier report flow. | Closed | Still closed; Phase 20 did not alter manifest generation. |
| ARCH-1 (prior) | P2 | Product spec needed bounded local read-only exchange import feature area aligned with ADR-002. | Closed | Still closed; Phase 20 did not add real exchange fetching. |
| CODE-2 | P2 | Imported CSV duplicate row ids could collide in attribution buckets. | Closed | Still closed; Phase 20 did not alter trade normalization or attribution. |

## Stop-Ship Decision

No - Phase 20 stays local, deterministic, claim-safe, privacy-safe, and within
the T0 runtime boundary. No P0/P1/P2 findings remain. Phase 21 evidence
dashboard work may begin.
